Cite
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.
MLA
Cailleteau, Axel, et al. “Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 Mg/M²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.” International Journal of Radiation Oncology, Biology, Physics, vol. 115, no. 3, Mar. 2023, pp. 677–85. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2022.09.069.
APA
Cailleteau, A., Maingon, P., Choquet, S., Bourdais, R., Antoni, D., Lioure, B., Hulin, C., Batard, S., Llagostera, C., Guimas, V., Touzeau, C., Moreau, P., Mahé, M.-A., & Supiot, S. (2023). Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma. International Journal of Radiation Oncology, Biology, Physics, 115(3), 677–685. https://doi.org/10.1016/j.ijrobp.2022.09.069
Chicago
Cailleteau, Axel, Philippe Maingon, Sylvain Choquet, Rémi Bourdais, Delphine Antoni, Bruno Lioure, Cyrille Hulin, et al. 2023. “Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 Mg/M²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.” International Journal of Radiation Oncology, Biology, Physics 115 (3): 677–85. doi:10.1016/j.ijrobp.2022.09.069.